October 21, 2019 - Page 17 of 20

TSX News - October 21, 2019

Balmoral’s Nickel Sulphide Portfolio Expands With Confirmation of Precious Metal Rich Nickel Discovery at Bluenose, Rum Project, Quebec

VANCOUVER, British Columbia, Oct. 21, 2019 (GLOBE NEWSWIRE) — Balmoral Resources Ltd. (“Balmoral” or the “Company”) (TSX: BAR; OTCQX: BALMF) […]

TSX Venture News - October 21, 2019

Calibre Mining Provides Partial Fourth Quarter 2019 Guidance: Expects Gold Production of Between 32,000 and 35,000 ounces at All-In Sustaining Costs(2) of Between US$950 and US$980 per ounce

VANCOUVER, British Columbia, Oct. 21, 2019 (GLOBE NEWSWIRE) — Calibre Mining Corp. (“Calibre” or the “Company”)(TSX: CXB) is pleased to […]

Canadian Stock Exchange News - October 21, 2019

PLUS Products Bolsters Research Expertise with the Addition of Chief Scientific Officer Dr. Ari Mackler

SAN MATEO, Calif., Oct. 21, 2019 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”) […]

NASDAQ Companies - October 21, 2019

Golar LNG Limited – Q3 2019 results presentation

Golar LNG’s 3rd Quarter 2019 results will be released before the NASDAQ opens on Tuesday November 26, 2019. In connection […]

NASDAQ Companies - October 21, 2019

Dr. Mark H. Pollack named Chief Medical Officer for Myriad Neuroscience

SALT LAKE CITY, Oct. 21, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]

NASDAQ Companies - October 21, 2019

Manhattan Bridge Capital, Inc. Reports Third Quarter 2019 Results

GREAT NECK, N.Y., Oct. 21, 2019 (GLOBE NEWSWIRE) —Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that total revenue for […]

NASDAQ Companies - October 21, 2019

Teradyne to Acquire AutoGuide Mobile Robots

AutoGuide offers uniquely modular autonomous mobile tuggers and forklifts for high-payload material transport of up to 10,000 pounds (4,500 kg).Autonomous […]

NASDAQ Companies - October 21, 2019

Axsome Therapeutics Completes Patient Enrollment in the CONCERT Phase 2 Trial of AXS-12 in Narcolepsy

NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]

NASDAQ Companies - October 21, 2019

Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037

EXTON, Pa., Oct. 21, 2019 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), or the Company, announced today that the […]

NASDAQ Companies - October 21, 2019

AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV Antibodies

–Data support safety and potential clinical utility of AGTC’s ocular gene therapy candidates regardless of patients’ AAV antibody status-GAINESVILLE, Fla., […]